language:
Find link is a tool written by Edward Betts.searching for Blocking antibody 22 found (30 total)
alternate case: blocking antibody
Nivolumab/relatlimab
(761 words)
[view diff]
exact match in snippet
view article
find links to article
programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody. It is given by intravenous infusionRelatlimab (312 words) [view diff] case mismatch in snippet view article find links to article
S2CID 245407697. "U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag (nivolumab and relatlimab-rmbw), as TreatmentAPRIL (protein) (1,508 words) [view diff] exact match in snippet view article
ISBN 978-0-387-89519-2. PMID 19760066. "Development of a first in class APRIL fully blocking antibody BION-1301 for the treatment of multiple myeloma". AACR 2017 ProceedingsLanadelumab (1,272 words) [view diff] exact match in snippet view article find links to article
"Inhibition of plasma kallikrein by a highly specific active site blocking antibody". The Journal of Biological Chemistry. 289 (34): 23596–23608. doi:10SillaJen (764 words) [view diff] case mismatch in snippet view article find links to article
Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular CarcinomaHemagglutination assay (1,501 words) [view diff] exact match in snippet view article find links to article
inhibit agglutination between virus and RBCs, as well as potentially blocking antibody from binding to virus. Receptor-destroying enzymes (RDE) are commonlyWnt signaling pathway (7,427 words) [view diff] exact match in snippet view article find links to article
PMID 24492943. Gao W, Xu Y, Liu J, Ho M (May 2016). "Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate". ScientificCCL2 (2,415 words) [view diff] exact match in snippet view article find links to article
MURINE GAMMAHERPESVIRUS68 IN COMPLEX WITH THE P8A VARIANT OF CC-CHEMOKINE MCP-1 2bdn: Crystal structure of human MCP-1 bound to a blocking antibody, 11K2Lifileucel (590 words) [view diff] exact match in snippet view article find links to article
the body) melanoma previously treated with other therapies (a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or withoutOcular myasthenia (1,452 words) [view diff] exact match in snippet view article find links to article
can also be confirmed with blood work that measures the amount of blocking antibody present, but only 70% of ocular MG patients have detectable antibodyHeparan sulfate (4,149 words) [view diff] exact match in snippet view article find links to article
PMID 24492943. Gao W, Xu Y, Liu J, Ho M (May 2016). "Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate". ScientificPTPN22 (3,898 words) [view diff] exact match in snippet view article find links to article
expansion in vivo. Treatment of PTPN22-deficient mice with an anti-GITR-L blocking antibody suppresses the expansion of Treg cells. PTPN22 deficiency does notOmalizumab (4,909 words) [view diff] exact match in snippet view article find links to article
Scheinfeld N (2005). "Omalizumab: a recombinant humanized monoclonal IgE-blocking antibody". Dermatol. Online J. 11 (1): 2. doi:10.5070/D30MC9C9TW. PMID 15748543Glypican (2,445 words) [view diff] exact match in snippet view article find links to article
Liu, Jian; Ho, Mitchell (May 17, 2016). "Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate". ScientificInterleukin 6 (7,425 words) [view diff] exact match in snippet view article find links to article
by exercise in human adults can be reversed by the IL-6 receptor blocking antibody tocilizumab. Together with the findings that IL-6 prevents obesityGlypican 3 (2,625 words) [view diff] exact match in snippet view article find links to article
PMID 21112773. Gao W, Xu Y, Liu J, Ho M (May 2016). "Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate". ScientificPexastimogene devacirepvec (1,775 words) [view diff] case mismatch in snippet view article find links to article
Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma"Bristol Myers Squibb (7,411 words) [view diff] exact match in snippet view article find links to article
(megestrol acetate) Opdivo (nivolumab) is a programmed death receptor blocking antibody used for the treatment of unresectable or metastatic melanoma andMelanoma (15,963 words) [view diff] case mismatch in snippet view article find links to article
PMID 24912947. "U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag (nivolumab and relatlimab-rmbw), as TreatmentCancer immunotherapy (9,629 words) [view diff] case mismatch in snippet view article find links to article
and subsequently, protein pores are formed in cancer cell membrane. Blocking Antibody therapies can also function by binding to proteins and physicallyBradley J. Monk (3,280 words) [view diff] exact match in snippet view article find links to article
of determining the efficacy of the programmed cell death-ligand 1 blocking antibody, durvalumab, with and following concurrent chemoradiotherapy versusStichodactyla toxin (8,630 words) [view diff] exact match in snippet view article find links to article
Schultz PG, Wang F (October 2016). "Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant". Proceedings of the National Academy